At a glance
- Originator Israel Institute for Biological Research
- Class Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 20 Jan 1997 No-Development-Reported for Cognition disorders in Israel (Unknown route)